Download ruđer bošković institute zagreb, bijenička 54 croatia

Current status and future prospectives of
technology transfer at the Croatian Ruđer
Bošković Institute
Danica Ramljak, D.V.M., Ph.D.
INSTITUTE
20 000 2 area
TODAY
IRB OVERVIEW BY BRANCHES
TOTAL = 867 EMPLOYEES
542 RESEARCH STAFF (344 WITH PhD) +
325 SUPPORT AND TECHNICAL STAFF
> 200 znanstvenih novaka
198
34
YOUNG RESEARCHERS
YOUNG RESEARCHERS WITH PhD
118
95
97
SENIOR RESEARCH ASSOCIATES
RESEARCH ASSOCIATES
SENIOR RESEARCHERS
MISSION
High quality basic research
Strong involvement in higher education
Leading contribution to the growth of the national economy
VISION
EU Centre of scientific excellence
Delivering knowledge and values to industry, government and
academic institutions
SCIENTIFIC PUBLICATIONS
RBI scientists - 6% of the total no. of scientists in Croatia
 32 % of all Croatian articles cited in Current Content
CC Papers: 2004 - 2009
2004
2005
2006
2007
2008
2009
364
389
356
408
406
440
How can the best scientific institute
in Croatia contribute to development
of the TT and National Innovation
System?
THERE IS NO EFFICIENT TT and INNOVATION SYSTEM
WITHOUT:
•
Strong basic research
•
Strong applied research
•
Strong cooperation between scientific community, academia and industry
•
Strong education system
•
Strong leadership
•
STRONG NATIONAL GOVERNMENT COMMITMENT
INNOVATIONS
FUNDING
IDEAS
IP AND
PATENTS
TECHNOLOGY
TRANSFER
Intellectual Property and
Commercialization

RBI’s Agency founded in 2007
 specialized in commercialization of innovations and
technology transfer
 links science and technology with economy and
industry.
Portfolio: more than 80 innovations and scientific projects in
various fields with commercial potential but primarily in
chemistry, medicine, biology, physics and informatics
 7 employees,
 more than 80 projects (32 outside RBI),
 32 patent applications
 7 license agreements, 1 patent granted and 5 spin-offs
Spin off companies
Ruđer Innovations
• Commercialization of innovations and technology transfer
Ruđer Medikol Cyclotrone
• Development and production of radionuclides
Ruđer Medikol Diagnostics
• Breast and other genetic hereditary diagnostics
Initium Futuri
• Innovative ICT technologies
BioZyne (in formation)
• Biotech company for R&D in the life sciences (cancer drugs)
•
IF IN NUMBERS
•
•
•
Investment: 154kEUR
Ownership: RI 51%, inventors (4) 49%
Profit sharing: RI:51%, inventors (4) 49%
Year
2007
2008
Sep 2009
Expected
in 2009
2010
2011
Staff
4
5
5
5
6
6
Projects
3
4
5
5
6
7
Licences, business
contr.
0
1
2
2
4
6
Revenue (EUR)
0
26631,72
38125,56
cca.
72000
100
150
13
IF PROJECT PORTFOLIO
•
SmartECG - Mobile Heartwork analysis and alarming system
•
Vergilius – Navigation for visually impaired
•
Eduforia – eLearning and collaboration software
•
ePortfelj – Web 2.0 personal investment portfolio manager
•
Custom software and consulting services – one big BPR (Business Process
Reengineering) project in progress
14
RMD IN NUMBERS
•
•
•
Investment: 50kEUR
Ownership: RI 50%, Medikol 50%
Profit sharing: RI:80%,Medikol 20%
Year
2008
Sep 2009
Staff
1
1
Projects/diagnoses?
0
2
Revenue (k EUR)
0
2
19
9
Costs (k EUR)
15
Do research and TT at IRB need
improvement ?
YES !
RBI  EU CENTRE OF EXCELLENCE
IMPROVE
INTEGRATION
VISIBILITY
INTERNATIONAL
COOPERATION
EDUCATION
PATENTS,
FUNDRAISING
IMPROVE
RESEARCH
INFRASTRUCTURE
INCREASE
IMPACT PAPERS #INTERNATIONA
L PROJECTS
COOPERATION
WITH INDUSTRY
VISIT TO WEIZMANN INSTITUTE
THANK YOU !